Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Stock indices are calculated by dedicated index providers using specified methodologies and governance processes. This article explains who does the work and why it matters.
16,076 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Artificial intelligence is reshaping capital flows across tech and beyond. This guide identifies three core AI infras...
As investors await gatx (gatx) 2025 earnings, this guide breaks down what to watch in the quarterly results, how the ...
Energy Transfer is shifting from a pure yield play to a growth story as key midstream projects advance. This long-for...
A new AI-driven marketing platform is raising Reg A+ funds at $0.85 per share, pitching a fast-growth TMT play for in...
A surge in exports, a stronger currency, and deep reform push lift a frontier market into fresh highs. The world’s ho...
A major advisory firm made a multi-million dollar bet in a large-cap growth ETF, catching the eye of everyday investo...
If you have $1,000? these stocks could form the core of a solid, long‑term portfolio. Learn why two consumer staples ...
Two years of rapid expansion can propel small innovators into the spotlight. This guide breaks down how to spot real ...
NVIDIA is signaling a bold push into faster AI inference with a new chip design. This move could reshape cloud comput...
Target reports a Q4 EPS beat on margin gains even as customer visits declined. The results highlight a bifurcated pat...
IAMGOLD has rocketed higher over the past year, with a 273% gain in 12 months. The driving force is not just gold's r...